ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Platinum-containing heterometallic complexes in cancer therapy: advances and perspectives

Ma, Lili; Li, Luwei; Zhu, Guangyu*hebei univ
Inorganic Chemistry Frontiers2022-5-31DOI: 10.1039/d2qi00205a
28被引10阅读
引用收藏
分享

摘要

Platinum-based anticancer drugs are among the most widely used antineoplastics in clinical settings. Their therapeutic applications and outcomes are, however, greatly hampered by drug resistance, systemic toxicity, and the lack of antimetastatic and diagnostic properties. The incorporation of second metal centers with distinct biological targets and favorable physical and chemical properties into platinum complexes is a promising strategy to improve the anticancer efficacy of platinum drugs and overcome their shortcomings. This review focuses on Pt-containing heterometallic complexes Pt-M (M = Ru, Au, Ti, Fe, Rh, Pd, Cu, Ir, Gd, Eu, Re, and Tc) for cancer therapy. The design, anticancer activities, mechanism of action, and interplay between Pt and the second metal center are discussed. Many dual-pharmacophore heterometallic complexes have shown a great potential for overcoming cisplatin resistance. Besides, the incorporation of Ru(iii) or areneRu(ii) moieties into Pt complexes has been proved to inhibit cancer metastasis effectively. Moreover, theragnostic heterometallic complexes have been obtained by combining cytotoxic Pt and luminescent Eu(iii), MRI responsive Gd(iii), or radioactive Tc-99m(i) into a single molecule. We also discuss the photophysical and bioimaging properties of theragnostic heterometallic complexes. This review provides a comprehensive landscape of representative examples of Pt-containing heterometallic complexes investigated in the last decade for cancer therapy and may guide researchers in exploring the challenges and opportunities in this emerging field.

学科与关键词

关键词
NUCLEOPHILIC-SUBSTITUTION REACTIONSANTICANCER ACTIVITYHETEROBIMETALLIC COMPLEXESCOPPER-COMPLEXESDNA CLEAVAGEPT-IVAGENTSBINDINGCISPLATINMETAL
相关
加载中…
  • Recent Advances of Platinum-Based Anticancer Complexes in Combinational Multimodal Therapy
    Zhong, Tianyuan; Yu, Jie; Pan, Yong; Zhang, Ning; Qi, Yanxin*; Huang, Yubin*Advanced Healthcare Materials, 2023, 12(22).被引 8
  • Beyond mere DNA damage: Recent progress in platinum(IV) anticancer complexes containing multi-functional axial ligands
    Deng, Zhiqin; Zhu, Guangyu*Current Opinion in Chemical Biology, 2023, 74: 102303.被引 10
  • Biomedical applications of Pt(II) metallacycle/metallacage-based agents: From mono-chemotherapy to versatile imaging contrasts and theranostic platforms
    Tuo, Wei; Xu, Yuling; Fan, Yifan; Li, Jun; Qiu, Mingqiang; Xiong, Xiaoxing*; Li, Xiangyang*; Sun, Yao*Coordination Chemistry Reviews, 2021, 443: 214017.被引 49
查看全部 →

发表信息

论文状态
公开发表
期刊
Inorganic Chemistry Frontiers
发表日期
2022-05-31
卷期
第 9 卷, 第 11 期
页码
2424-2453
DOI
10.1039/d2qi00205a
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [22077108, 21877092, 22007027]; Hong Kong Research Grants Council [11304318, 11307419, 11303320, 11302221]; Science Technology and Innovation Committee of Shenzhen Municipality [JCYJ20210324120004011]; Natural Science Foundation of Hebei Province [B2019201465]; Science Fund for Creative Research Groups of Nature Science Foundation of Hebei Province [B2021201038]; Selected Returned Overseas Professionals Project of Hebei Province [C20200304]

作者

  • M

    Ma, Lili (第一作者)

    hebei univ

  • L

    Li, Luwei

    hebei univ

查看全部 3 位作者收起作者
  • Z

    Zhu, Guangyu (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417